...study received steroids. Novaferon is a pegylated IFNα product from Genova...
...the proportion of patients virus-negative at day six.Genova did...
...Pegylated Interferon Lambda) Traumakine (FP-1201, FP-1201-lyo, MR11A8) Rebif, interferon beta-1a Genova...

...of Bologna Alma Mater Studiorum, Bologna, Italy email: andrea.cavalli@unibo.it CONTACT: Nicoletta Pedemonte, Giannina Gaslini Institute, Genova...

...advisor China Renaissance, the investment is part of Genova’s series B round. Founded in 2014, Genova...
...& Healthcare Construction and Development Co. Ltd. Genova could not be reached for comment. Allison Johnson insulin glargine Genova...

...la Sante et de la Recherche Medicale , Paris, France Italian Institute of Technology , Genova...

...University of Pisa, Pisa, Italy e-mail: aros@farm.unipi.it Contact: Marina Fabbi, National Institute of Cancer Research, Genova...

...research on their respective programs. Further details were not disclosed (see BioCentury, Sept. 21). Separately, GENova...
...a letter of intent for exclusive rights to the college's IP covering cancer stem cells. GENova...
...to treat breast cancer. Further terms were not disclosed. Bridge Bioresearch plc , London, U.K. GENova Biotherapeutics Inc....

...GENova will acquire three patents covering undisclosed targets from an undisclosed company. GENova is developing tetanolic...
...treat breast cancer, with other compounds to treat prostate cancer. Also, in two separate deals, GENova...
...is focused on Type II diabetes, obesity and cardiovascular disorders. Further terms were not disclosed. GENova Biotherapeutics Inc....

...J. Med. Chem.; published online June 23, 2009; doi:10.1021/jm900225j Contact: Fabio Sparatore, University of Genova, Genova...

...et al. Blood; published online May 12, 2008; doi:10.1182/blood-2008-02-139378 Contact: Irma Airoldi, G. Gaslini Institute, Genova...